Sun Pharma and Moebius Medical publish clinical and mechanistic data on non-opioid knee… EP News Bureau Apr 24, 2025 Phase 2b study and supporting research highlight MM-II’s potential in symptomatic knee osteoarthritis; new findings presented at…
Sun Pharma and Moebius Medical gain fast track designation for MM-II for the treatment of… EP News Bureau Sep 6, 2024 MM-II is a novel non-opioid product that uses a proprietary suspension of large, empty, multilamellar liposomes which are intended…
